Booster shot increases protection against COVID-19: Turkish health minister

In a written statement issued after the virtual meeting of the Coronavirus Scientific Advisory Board, Fahrettin Koca said people who have received three shots account for less than 2% of overall coronavirus cases in Turkey.

The COVID-19 booster shot increases protection against the disease, the Turkish health minister said on Wednesday.

In a written statement issued after the virtual meeting of the Coronavirus Scientific Advisory Board, Fahrettin Koca said people who have received three shots account for less than 2% of overall coronavirus cases in Turkey.

Nearly 90% of active cases in hospitals are people who have not been vaccinated or received only one jab, he detailed, adding that only 10% of fully vaccinated people are currently receiving hospital treatment.

It is also expected that those who had received two doses of mRNA vaccines would need a booster shot 5-6 months after they got the second dose, he said.

"About 6 million of our citizens are eligible to receive their booster shots," Koca stated, calling on them to "not waste time" to receive their jabs.

Turkey has administered over 99.64 million coronavirus vaccine shots since the country launched an immunization campaign in January, according to official figures released on Wednesday.

Over 50.68 million people in Turkey have gotten their first doses, while more than 39.33 million are fully vaccinated, the Health Ministry said.

The data showed that 81.6% of the country's adult population has received at least one dose of a two-shot vaccine.

Turkey has also given third shots to over 9.2 million people.

The ministry also reported 23,914 new coronavirus cases, while as many as 262 more people died of the disease in the past 24 hours.

Earlier, Koca announced that the first cases of COVID-19 Mu variant were seen in Turkey.

First identified in Colombia this January, the Mu strain has been found in 39 countries so far and was recently classified as a "variant of interest" by the World Health Organization.

The variant accounted for less than 0.1% of infections worldwide, but its prevalence in Colombia and Ecuador has been rising and stood at 39% and 13%, respectively, by the end of August, according to the WHO.

X
Sitelerimizde reklam ve pazarlama faaliyetlerinin yürütülmesi amaçları ile çerezler kullanılmaktadır.

Bu çerezler, kullanıcıların tarayıcı ve cihazlarını tanımlayarak çalışır.

İnternet sitemizin düzgün çalışması, kişiselleştirilmiş reklam deneyimi, internet sitemizi optimize edebilmemiz, ziyaret tercihlerinizi hatırlayabilmemiz için veri politikasındaki amaçlarla sınırlı ve mevzuata uygun şekilde çerez konumlandırmaktayız.

Bu çerezlere izin vermeniz halinde sizlere özel kişiselleştirilmiş reklamlar sunabilir, sayfalarımızda sizlere daha iyi reklam deneyimi yaşatabiliriz. Bunu yaparken amacımızın size daha iyi reklam bir deneyimi sunmak olduğunu ve sizlere en iyi içerikleri sunabilmek adına elimizden gelen çabayı gösterdiğimizi ve bu noktada, reklamların maliyetlerimizi karşılamak noktasında tek gelir kalemimiz olduğunu sizlere hatırlatmak isteriz.